UEMS Medical Specialty
Immunology & Allergology
Research dossiers on immune modulation, anti-inflammatory nutraceuticals, cytokine pathway interventions, and allergological applications.
24
dossiers
Intracellular Defense & IV-Alternatives
Integrated Metabolic Pathways for Immune Support, Fatigue Reduction, and Cellular Protection: A Mechanistic Review
Designing effective nutritional or pharmaco-nutritional interventions is challenging given the complex, interconnected nature of metabolic pathways supporting immunity, energy, and cellular protection. Delivering pleiotropic compounds efficiently to multiple intracellular targets without systemic burden is critical.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Interventions in Neurodegeneration: Mechanisms, Clinical Efficacy, and Therapeutic Challenges
Developing clinically robust and compliant ketogenic interventions for neurodegenerative diseases requires overcoming challenges related to variable metabolic responses, sustained therapeutic ketosis, and precise delivery of ketone bodies or precursors in diverse patient populations.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Borna Disease Virus 1: An Emerging Cause of Fatal Human Encephalitis
The critical challenge lies in developing effective, brain-penetrant antiviral agents and neuroprotective therapies for BoDV-1 encephalitis, compounded by diagnostic difficulties and a very narrow therapeutic window due to rapid progression and high fatality rates.
Intracellular Defense & IV-Alternatives
Bornaviruses: Genome Organization, Nuclear Replication, and Gene Expression Mechanisms
Developing effective antiviral therapies for nuclear-replicating RNA viruses like Bornaviruses requires deep understanding of their unique genomic organization and complex gene expression mechanisms, posing significant challenges for targeting viral replication without host toxicity.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Glioblastoma: Epidemiology, Pathology, Molecular Biology, and Therapeutic Landscape
Developing effective glioblastoma therapies is hampered by the tumor's aggressive proliferation, profound intratumoral heterogeneity, and the inherent difficulty in delivering therapeutic agents across the blood-brain barrier to the highly immunosuppressive microenvironment.
Precision Microbiome & Gut-Brain Axis
Norovirus: Virology, Epidemiology, Clinical Disease, Prevention, and Treatment Review
Developing effective norovirus vaccines and direct-acting antivirals is challenged by viral genetic diversity, genotype-specific host tropism, and the absence of a definitive cellular receptor. Current supportive care highlights an urgent need for targeted interventions.
Precision Microbiome & Gut-Brain Axis
Rheumatoid Arthritis and Mental Health: Psychoneuroimmunological Links and Therapeutic Implications
The primary challenge is to develop targeted therapeutic and nutritional interventions that modulate inflammatory pathways and the HPA axis to improve mental health outcomes in patients suffering from chronic autoimmune conditions like rheumatoid arthritis.
Cellular Longevity & Senolytics
Major Advances in Rheumatology: 2025–2026 Breakthroughs
Developing advanced cellular and biologic therapies for chronic autoimmune diseases requires overcoming significant challenges in targeted delivery, achieving immune modulation without broad immunosuppression, and ensuring long-term drug-free remission.
Catecholamine Homeostasis & Executive Function
Psychological State and Cancer: Modulatory Roles in Progression and Outcomes
Developing targeted therapies that address the modulatory effects of chronic psychological stress and associated neuroendocrine pathways on tumor progression and patient outcomes in oncology remains a complex challenge.
Transmucosal Delivery & Dosage Form Engineering
Comparative Review of Topical Therapies for Atopic Dermatitis: Efficacy and Safety
Developing topical treatments for atopic dermatitis requires balancing potent anti-inflammatory efficacy with minimal local and systemic adverse effects, ensuring patient adherence, and optimizing transdermal delivery through a compromised skin barrier.
Precision Microbiome & Gut-Brain Axis
Hidden Pharmacodynamics of Pharmaceutical Formulations: Excipient, Impurity, and Oxidation Index Impact on Clinical Safety
Pharmaceutical and nutraceutical formulations often overlook the direct pharmacodynamic effects of excipients and the toxicity of oxidation byproducts, risking unforeseen clinical safety issues that extend beyond the API's profile.
Precision Microbiome & Gut-Brain Axis
Gut-Brain Axis and Mental Illness: Microbiota, Mechanisms, and Testable Hypotheses
Translating complex gut-brain axis insights into effective, targeted formulations for psychiatric conditions requires addressing variable microbiome signatures, diverse mechanistic pathways, and inconsistent clinical trial outcomes.
Cellular Longevity & Senolytics
Immunometabolism, Active Resolution of Inflammation, and Specialized Pro-resolving Mediators (SPMs) from EPA/DHA
Current anti-inflammatory strategies often inhibit active resolution pathways, leading to chronic inflammation. Developing stable, bioavailable specialized pro-resolving mediators (SPMs) or modulators that enhance endogenous SPM biosynthesis without compromising resolution is a significant challenge.
Precision Microbiome & Gut-Brain Axis
The Neuroimmune Continuum: Mechanisms, Paradigm Shifts, and Translational Frontiers in Psychoneuroimmunology
Translating complex psychoneuroimmunological mechanisms, including BBB permeability, specific cytokine pathways, and targeted microglial modulation, into stable and bioavailable therapeutic formulations presents a significant CDMO hurdle.
Intracellular Defense & IV-Alternatives
Personalized mRNA Neoantigen Vaccines: Efficacy and Safety in Melanoma and PDAC
Developing personalized mRNA neoantigen vaccines requires rapid, custom manufacturing workflows within a narrow therapeutic window, presenting significant logistical and scale-up complexities for widespread clinical adoption.
Cellular Longevity & Senolytics
Cellular Senescence, SASP, and Senolytic Targeting of Age-Related Pathologies
Delivering senolytics effectively to specific senescent cell populations and overcoming their multi-pathway pro-survival redundancy (SCAPs) without off-target effects remains a significant challenge for therapeutic development.
Intracellular Defense & IV-Alternatives
De Novo Generative AI Drug Design: Clinical Progress and Methodological Landscape
Developing novel therapeutic molecules with high specificity and optimized pharmacological profiles rapidly, particularly for challenging targets, requires innovative and efficient design methodologies beyond traditional discovery pipelines.
Microvascular Hemodynamics & Endothelial Integrity
Xenotransplantation Progresses to Formal Clinical Trials: A 2026 Update on Pig-to-Human Organ Transplants
Developing xenotransplant grafts that overcome immediate immune rejection and ensure long-term physiological compatibility requires sophisticated genetic engineering and precise immunomodulatory strategies.
Intracellular Defense & IV-Alternatives
Isomeric Stabilization in High-Moisture Matrices: Protecting Fixed-Ratio Inositol Formulations
Fixed-ratio solid formulations are prone to segregation during manufacturing, especially under moisture-driven property changes, causing dose uniformity and accuracy challenges.
Intracellular Defense & IV-Alternatives
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate formulation for active labour is challenging due to delayed gastric emptying, high aspiration risk, and the need to prevent maternal and neonatal dysglycemia. Current oral options are inadequate, often necessitating IV administration.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Ketogenic Diet-Specified Interventions in Neurodegenerative Disease Mechanisms
Developing a formulation that achieves consistent and measurable ketosis while optimizing bioavailability and tolerability in neurodegenerative conditions is a key challenge.
Intracellular Defense & IV-Alternatives
Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies
Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.
Intracellular Defense & IV-Alternatives
Non-Destructive Raman Spectroscopy for PAT-Based Botanical Contaminant Detection
Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.
Precision Microbiome & Gut-Brain Axis
Gut-Brain Axis in ADHD: Microbiota-Mediated Dopaminergic Pathway Modulation
Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.